| Entry |
|
| Name |
Baminercept (USAN/INN);
Baminercept alfa (USAN)
|
| Formula |
C4074H6282N1134O1274S68
|
| Exact mass |
93650.2648
|
| Mol weight |
93710.7243
|
| Sequence |
AVPPYASENQ TCRDQEKEYY EPQHRICCSR CPPGTYVSAK CSRIRDTVCA TCAENSYNEH WNYLTICQLC RPCDPVMGLE EIAPCTSKRK TQCRCQPGMF CAAWALECTH CELLSDCPPG TEAELKDEVG KGNNHCVPCK AGHFQNTSSP SARCQPHTRC ENQGLVEAAP GTAQSDTTCK NPLEPLPPEM SGTMVDKTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP G (Disulfide bridge: 12-27; 28-41; 31-49; 52-67; 70-85; 73-93; 95-101; 108-117; 111-136; 139-154; 160-179; 236-296; 342-400, Dimer: 201; 204) |
| Type |
Peptide |
| Activity |
Treatment of rheumatoid arthritis
|
| Comment |
Fusion protein
|
| Target |
|
| Pathway |
|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines
TNF family
LTB [HSA:4050] [KO:K03157]
Baminercept
D08866 Baminercept (USAN/INN); Baminercept alfa (USAN)
 |
| Other DBs |
|